PPT-EGFR Mutation in Lung Adenocarcinoma (ADC)

Author : QuietConfidence | Published Date : 2022-08-04

Ana Rima Lung Cancer Incidence and Mortality New cases in 2013 228190 40 with stage IV disease at presentation 90000 160000 deaths in 2012 comparable to prostate

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "EGFR Mutation in Lung Adenocarcinoma (A..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

EGFR Mutation in Lung Adenocarcinoma (ADC): Transcript

Ana Rima Lung Cancer Incidence and Mortality New cases in 2013 228190 40 with stage IV disease at presentation 90000 160000 deaths in 2012 comparable to prostate pancreas breast and colon cancer combined. Colin Reisterer and Nick Swenson. S. . Maheswaran. et al. . The New England Journal of Medicine. . 2007. http://www.all-cancer-treatments.com/types-of-lung-cancer.html. Clinical background: Non-small cell lung cancer (NSCLC). September 6, 2014 | Boston. In ALK, ROS1 & EGFR Lung Cancers. Combinations for Treating EGFR Acquired Resistance. Melissa L. Johnson, MD. Dx. : EGFR+ lung cancer. Acquired Resistance. TKI. s. . and . related. . treatment . strategies. Rafal . Dziadziuszko. Medical. . University. of Gdańsk, Poland. 16th European . Congress. „. Perspectives. in . Lung. Cancer. ” . Torino. On behalf of the North of England Cancer Network Lung NSSG. Dr Naomi Chamberlin, Dr Ann Ward. Aims. Overview of brief. Method. Contributing Trusts. Results. Discussion. Overview of brief. To gather data on all patients with a diagnosis of non-small cell lung cancer across the Network for whom specimens have been sent for EGFR mutation testing.. attraverso . i . c. asi clinici. Giuseppe . Valmadre. Claudia . Maggioni. NSCLC ALGORITMO TERAPEUTICO. Generale. 1 .ADENOCARCINOMA 1 linea. Mutazione EGFR o . Traslocazione. ALK positivo. Mutazione EGFR o . Data source: . Wang R, Pan Y, Li C, et al. Analysis of major known driver mutations and prognosis in resected . adenosquamous. lung carcinomas. J . Thorac. . Oncol. . 2014;9:760-8. . Kohno T, . Nakaoku. The Coming Paradigm Shift. Faculty. Suresh S. Ramalingam, MD. Professor of Hematology/Oncology . Director, Lung . Cancer Program . Winship Cancer Institute. Emory University. Atlanta, . Georgia. Program Goals. This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal.. A. HRICHI, S. KOUKI, M. LANDOULSI ,R. AOUINI, I. GANZOUI, S.BOUGUERRA, Y. AROUS, H. BOUJEMAA, N. BEN ABDALLAH. Radiology service, Main Military hospital of Instruction of Tunis, Tunisia. CH7. Inroduction. Consequences of the Lack of Patients of color & Structural barriers to Quality. Christopher S. Lathan, M.D., M.S., M.P.H. Assistant Professor of Medicine. Faculty Director of Cancer Care Equity, Dana-Farber Cancer Institute. Cécile Jovelet. Postdocoral. . fellow. Translational. . research. . lab. Gustave Roussy Institute, France. Introduction . 12/04/2017. 2. Lung cancer: . third most frequent cancer. Non-Small Cell Lung Cancer (NSCLC): 80% cases of lung cancer. Lei Zhao. 1*. , . Marco Lequio. 2,3*. , . Ziwen. Zhu. 3. , . Huaping. Xiao. 2,4. , Jacob Lee. 3. , . Tianru. Shi. 2. , Qian Bai. 3. , Aldo G. Dominguez. 3. , Mark R. Wakefield. 3. , . Yujiang. Fang. , MD. Dermatopathologist. &. neuropathologist. 95. % . of primary lung tumors are . carcinomas. . hamartoma. The most common benign tumor . It’s clonal, so the name . hamartoma. is a misnomer. 114 , Khaled Mahmoud Kamel , Ahmed Al Halfawy , Hassan Amin Sabah Ahmed Hussein , Hassan Gamal Yamamah , Mohamed Shaaban Mousa Lung Adenocarcinoma Presented with Extensive Calcification in lun

Download Document

Here is the link to download the presentation.
"EGFR Mutation in Lung Adenocarcinoma (ADC)"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.